William Withering: Digitalis Discovery and Botanical Legacy

William Withering (1741–1799) was an English physician, botanist, and chemist. He did not discover the circulatory system (Harvey, 1628). His landmark contribution was the clinical introduction of digitalis (foxglove) for dropsy (heart failure).

Key Achievements

• 1785: "An Account of the Foxglove" — 156 cases treated with standardized digitalis leaf preparation; documented dose, effect, toxicity.
• Established the therapeutic window concept: narrow margin between efficacy (diuresis) and toxicity (nausea, arrhythmia).
• Laid foundation for modern cardiac glycoside therapy (digoxin).

Botanical Work

• "A Botanical Arrangement of British Plants" (1776) — Linnaean classification; multiple editions.
• Discovered several plant species; studied fungi, mineralogy.
• Fellow of Royal Society; Lunar Society member (Boulton, Watt, Priestley).

Digitalis Mechanism (Modern Understanding)

• Inhibits Na⁺/K⁺-ATPase → ↑ intracellular Na⁺ → ↓ Na⁺/Ca²⁺ exchange → ↑ intracellular Ca²⁺ → ↑ contractility.
• Vagal stimulation → ↓ AV node conduction (rate control in AF).

Legacy

Withering transformed a toxic folk remedy into the first evidence-based cardiovascular drug. His systematic approach — observation, standardization, dose-finding, toxicity recognition — remains a model for translational pharmacology.